The GJB2 gene gives instructions for a protein that lets nearby cells pass signals to each other, especially in the inner ear. The protein made by this gene helps your cells work together to support normal hearing. If you carry a harmful variant that disrupts this process, hearing loss may be present at birth or appear early in life. Some variants in the GJB2 gene can also affect the skin, though hearing changes are the best known effect.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the information needed to make proteins, which are the working parts of cells. Others mainly help determine when certain processes take place, where they occur, and how strongly they operate. Taken together, genes affect how the body develops and works, and they can also influence how you respond to food, stress, or medications. For a more detailed look at this topic, you can find more in the LearnHub.
Overview
GJB2Gene function
What if the gene works
The GJB2 gene helps make connexin 26, a protein that lets nearby cells pass signals and small molecules. This is especially important in the inner ear and skin, where it supports normal hearing and healthy cell communication.
Risk
What if the gene does not work
Variants in the GJB2 gene often affect hearing from birth or early childhood, ranging from mild to profound hearing loss. More disruptive variants can cause earlier, greater hearing changes, and some also lead to skin findings.
Treatment
What does that mean for your treatment
For pathogenic variants in the GJB2 gene, no GJB2-specific treatment or drug choice is currently established. Care is guided by a person’s hearing needs rather than by a medicine selected for the GJB2 gene. The GJB2 gene is being studied as a target for inner ear gene therapy, but that remains investigational.
Conditions associated with GJB2
Gene function
What if the gene works
Hearing and skin both depend on smooth communication between neighboring cells. The GJB2 gene gives cells instructions to make connexin 26, a protein that forms tiny channels linking one cell to the next. This cell-to-cell signaling is a key part of how the GJB2 gene supports hearing and helps tissues work together.
Connexin 26 joins with matching proteins to form channels between neighboring cells. These channels create direct paths for cells to share signals instead of working alone.
Channels made with connexin 26 let small charged particles, including potassium, move from cell to cell. This steady flow helps tissues keep their internal balance.
In the inner ear, support cells use these channels to pass along potassium after sound is detected. That recycling helps hearing cells keep responding to everyday sounds.
By sharing small molecules between nearby cells, connexin 26 helps groups of cells act in a coordinated way. This supports normal routine activity in tissues such as the skin.
What is a variant?
A genetic variant is a small change in the DNA sequence within a gene. These changes are common and are part of normal human diversity, including differences in appearance, metabolism, and how the body responds to environmental influences. Many variants have no noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the GJB2 gene can change the connexin 26 protein so it folds poorly, breaks down early, or fails to form working channels between neighboring cells. Milder variants may leave some channel activity, while more severe variants can stop the protein from reaching the cell surface or prevent the channel from opening. These differences help explain how GJB2 gene variants affect hearing, with partial loss of function often linked to milder or later hearing changes and more disruptive variants more often linked to earlier, greater hearing loss.
How variants are linked to conditions
Variants in the GJB2 gene are a well-established cause of inherited hearing loss, especially hearing loss present at birth or in early childhood. GJB2 gene hearing loss is often nonsyndromic, meaning hearing is affected without other major health problems, though some specific variants can also cause conditions that include hearing loss with skin changes. Depending on the variant, the pattern in families may be recessive or dominant.
A variant is not necessarily a diagnosis
Gene variants are a normal part of human biology and are common throughout the general population. Most do not have a direct effect on health and instead reflect natural human diversity. For many genes, carrying a variant tied to a condition indicates a possible association rather than a definite diagnosis, especially when several genes and environmental factors also contribute. In some situations, though, a single well characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For GJB2, risk is driven mainly by the genetic changes inherited in the family. Having disease-causing changes in both copies of the GJB2 gene raises the chance of hearing loss far more than carrying one copy. Loud noise, certain medicines that can harm hearing, and repeated ear infections may worsen hearing over time.
Inheritance of GJB2 variants
How GJB2 variants are inherited depends on the specific condition and the variant. Most GJB2-related hearing loss follows an autosomal recessive pattern, which means a child inherits one variant from each parent, while each parent is often an unaffected carrier. Some GJB2-related conditions, including certain forms of hearing loss and skin related syndromes, follow an autosomal dominant pattern, so a parent with the variant can pass it to each child with a 50% chance. Because both patterns are well documented, the inheritance pattern for the GJB2 gene is not the same in every family.
What does my GJB2 result mean for my family?
For many GJB2 results, the main family impact depends on which hearing condition the result is linked to. Most often, GJB2-related hearing loss runs in families in a recessive pattern, which means parents, brothers, sisters, and future children may be carriers even if they do not have hearing loss. Some GJB2 changes act in a dominant pattern instead, so a parent, child, or sibling may also have the same variant or related hearing findings.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the GJB2 gene, a clinician can order GJB2 genetic testing for hearing loss using a blood sample, saliva, or a cheek swab. A lab reads the gene’s DNA code and reports whether a variant was found, which can help explain congenital or early childhood hearing loss.
When should I consider getting a genetic test?
Testing for changes in the GJB2 gene is often considered when a baby, child, or adult has unexplained hearing loss, especially if it started early in life or runs in the family. It can help confirm a genetic cause and may guide family planning and hearing care.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it reveals depends on the condition and on the type of variant involved. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body works. For some conditions, especially those shaped by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help make individual experiences easier to understand.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment works well for one person, has less effect in another, or causes more side effects in someone else. These differences are common and often relate to how the body absorbs, breaks down, transports, or responds to a drug.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way people respond to medications. By studying the links between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence either how the body processes a drug or how strong its effects are. This information can support treatment decisions that are more informed and more individualized. You can read more about this topic in the LearnHub.
Drugs influenced by the GJB2 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work, so questions about medications, side effects, or changes in your health are best discussed with your doctor.
History
Families and communities once noticed patterns of hearing loss that seemed to pass from parent to child. In the 1990s, researchers traced one of the most common inherited forms of childhood hearing loss to the GJB2 gene, a finding that marked a major step in hearing genetics. Early studies connected GJB2 variants with both recessive and dominant forms of hearing loss, helping explain why some families showed different inheritance patterns. From these first observations, research expanded steadily, and testing for GJB2 became a routine part of evaluating inherited hearing loss in many settings. Over time, this gene became one of the best known causes of nonsyndromic hearing loss, meaning hearing loss that happens without other major health features. Its discovery helped move care from describing hearing patterns alone to identifying a clear genetic cause in many families.